![]() |
市場調查報告書
商品編碼
1930118
全球機器人手術市場:市場規模、佔有率、成長率、行業分析、依類型、應用和地區劃分的分析以及未來預測(2026-2034 年)Robotic Surgical Procedures Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
受微創手術日益普及和手術機器人技術持續創新的推動,全球機器人手術市場正成為先進醫療技術領域成長最快的細分市場之一。根據 Fortune Business Insights 預測,該市場規模預計將在 2025 年達到 133.2 億美元,並在 2026 年顯著增長至 159 億美元,到 2034 年將達到 546.1 億美元。預計 2026 年至 2034 年的複合年增長率將達到 16.68%。
市場概覽
機器人手術(也稱為機器人輔助手術)使外科醫生能夠以更高的精確度、靈活性和控制力完成複雜的手術。這些手術廣泛應用於一般外科、婦科、泌尿外科和骨科等專科。微創技術、更短的住院時間、更快的復健速度和更佳的臨床療效日益受到青睞,這些都是推動機器人手術在全球普及的關鍵因素。
儘管新冠疫情在2020年導致市場急劇下滑14.3%,但此後市場呈現強勁復甦態勢。疫情期間,由於擇期手術的取消和延期,需求一度下降,但手術量的恢復已使市場成長恢復到疫情前的水準。
新冠疫情的影響
由於擇期手術的大規模取消,新冠疫情對機器人手術市場造成了負面影響。根據CovidSurg Collaborative統計,在疫情高峰期,全球約有2800萬例擇期手術被取消或延期。此外,包括直覺外科(Intuitive Surgical)在內的多家大型公司報告稱,2020年上半年收入下降約6.0%,主要原因是手術量下降和供應鏈中斷。然而,疫情後的復甦已顯著增強了市場需求。
市場規模及主要亮點
依地區劃分,北美在2025年佔全球市場的73.89%。這得益於該地區較高的手術量、先進的醫療基礎設施、有利的報銷政策以及機器人系統的快速普及。
成長因素
癌症、心血管疾病和骨科疾病等慢性病的增加是市場成長的主要驅動力。例如,前列腺癌病例預計將持續增長,從而促使機器人輔助根治性前列腺切除術數量的增加。此外,人口老化和久坐的生活方式也推動了對外科手術介入需求的成長。
技術進步也發揮關鍵作用。領先企業不斷推出新一代機器人系統。例如,Intuitive Surgical公司獲得FDA批准的達文西SP系統可實現複雜泌尿外科手術的單孔入路,顯著提高手術效率。
市場限制因子
儘管市場具有巨大的成長潛力,但機器人手術系統的高昂實施和維護成本也為市場帶來了挑戰。像達文西機器人這樣的系統每年的維護成本可能高達 10 萬至 15 萬美元,這意味著機器人手術比傳統腹腔鏡手術貴 3000 至 6000 美元。這些成本壁壘限制了機器人手術的普及,尤其是在新興經濟體。
依應用領域劃分,預計到 2026 年,普通外科手術將佔市場主導地位,市場佔有率達到 32.02%。這主要得益於子宮切除術、腎臟切除術和心臟瓣膜修復術等手術量的激增。由於骨科疾病的增加以及專業機器人平台的普及,預計骨科領域的複合年增長率將更高。泌尿外科和婦科預計在預測期內也將強勁成長。
The global robotic surgical procedures market has emerged as one of the fastest-growing segments within advanced medical technologies, driven by the increasing adoption of minimally invasive surgeries and continuous innovation in surgical robotics. According to Fortune Business Insights, the market was valued at USD 13.32 billion in 2025 and is projected to expand significantly to USD 15.9 billion in 2026, reaching USD 54.61 billion by 2034, registering a robust CAGR of 16.68% during 2026-2034.
Market Overview
Robotic surgery, also referred to as robot-assisted surgery, enables surgeons to perform complex procedures with enhanced precision, flexibility, and control. These procedures are widely used in general surgery, gynecology, urology, orthopedics, and other specialties. The growing preference for minimally invasive techniques, reduced hospital stays, faster recovery times, and improved clinical outcomes are major factors accelerating the adoption of robotic surgical procedures globally.
Despite a sharp decline of -14.3% in 2020 due to the COVID-19 pandemic, the market has shown a strong recovery trajectory. The cancellation and postponement of elective surgeries during the pandemic temporarily reduced demand; however, the resumption of surgical volumes has restored growth to pre-pandemic levels.
Impact of COVID-19
The COVID-19 pandemic negatively impacted the robotic surgical procedures market due to widespread cancellation of elective surgeries. According to the CovidSurg Collaborative, approximately 28 million elective surgeries were cancelled or postponed globally during peak disruption. Additionally, leading players such as Intuitive Surgical reported a revenue decline of around -6.0% in the first half of 2020, mainly due to reduced procedure volumes and supply chain disruptions. Nevertheless, post-pandemic recovery has significantly strengthened market demand.
Market Size and Key Highlights
In terms of regional dominance, North America accounted for 73.89% of the global market share in 2025, driven by high procedure volumes, advanced healthcare infrastructure, favorable reimbursement policies, and rapid adoption of robotic systems.
Driving Factors
The rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and orthopedic conditions is a key driver of market growth. For instance, prostate cancer cases are expected to increase steadily, leading to higher volumes of robot-assisted prostatectomy procedures. Additionally, the growing geriatric population and sedentary lifestyles are further contributing to the increased demand for surgical interventions.
Technological advancements also play a critical role. Leading companies are continuously introducing next-generation robotic systems. For example, Intuitive Surgical's FDA-approved da Vinci SP system has enabled single-port access for complex urological procedures, significantly enhancing surgical efficiency.
Market Restraints
Despite strong growth potential, the market faces challenges related to high acquisition and maintenance costs of robotic surgical systems. Annual maintenance costs for systems such as the da Vinci robot range between USD 100,000 and USD 150,000, while robotic procedures can cost USD 3,000-6,000 more than conventional laparoscopic surgeries. These cost barriers limit adoption, particularly in emerging economies.
By application, general surgery dominated the market, holding a 32.02% share in 2026, supported by the high volume of procedures such as hysterectomy, nephrectomy, and cardiac valve repair. Orthopedics is expected to grow at a higher CAGR due to increasing orthopedic disorders and the introduction of specialized robotic platforms. Urology and gynecology are also projected to witness strong growth during the forecast period.
Competitive Landscape
The market is largely dominated by Intuitive Surgical, owing to its strong product portfolio and global presence. Other key players include Stryker, Medtronic, Johnson & Johnson Services, Smith & Nephew, Zimmer Biomet, and CMR Surgical. Strategic acquisitions and partnerships remain a key trend, such as Medtronic's acquisition of Digital Surgery in 2020 to strengthen AI-driven robotic platforms.
Conclusion
In conclusion, the global robotic surgical procedures market is set for exceptional growth from USD 13.32 billion in 2025 to USD 54.61 billion by 2034, fueled by rising chronic disease prevalence, technological innovation, and increasing adoption of minimally invasive surgeries. Although high system costs remain a challenge, expanding reimbursement policies and continuous product advancements are expected to sustain strong market momentum throughout the forecast period.
Segmentation
By Application
By Geography